Nutraceutical News and Research

RSS

Nutraceutical, a portmanteau the words “nutrition” and “pharmaceutical”, is a food or food product that provides health and medical benefits, including the prevention and treatment of disease.

Study identifies role of additive monosodium glutamate in obesity and liver disease

The commonly used food additive monosodium glutamate (MSG) has been linked to obesity and disorders associated with the metabolic syndrome including progressive liver disease.

28 May 2014

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.

30 Apr 2014

Neutra to unveil new vapor pen at Cannabis Cup trade show

The executive leadership from Neutra Corp. will travel to Denver this week to seek out distribution and build brand awareness for the company's new vapor pen at one of the world's largest cannabis conventions: the Cannabis Cup.

17 Apr 2014

Neutra seeks new breakthroughs in greenhouse cultivation to develop and market around globe

In the company's quest to introduce new technology on the cutting edge of the indoor horticulture industry, Neutra Corp. (OTCBB: NTRR) is seeking out new breakthroughs in greenhouse cultivation to develop and market around the globe.

8 Apr 2014

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Otsuka Pharmaceutical Co., Ltd. has announced an agreement with Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. to acquire rights to the hematological cancer treatment Dacogen and to an enzyme inhibitor, E7727.

31 Mar 2014

Omega Protein's fourth quarter 2013 revenues increase 4% to $66 million

Omega Protein Corporation, a nutritional product company and a leading integrated producer of omega-3 fish oil and specialty protein products, today reported financial results for the fourth quarter and full year ended December 31, 2013.

10 Mar 2014

Neutra acquires cutting-edge developer of smoke-free nutraceutical delivery systems

Neutra Corp. (OTCBB: NTRR), a fast-growing provider of all-natural wellness solutions, announced today that it acquired Diamond Anvil Designs (DA), a cutting-edge developer of smoke-free nutraceutical delivery systems.

11 Feb 2014

Scientist receives grant to study biochemical fate of nanoemulsion-based food delivery systems in GI tract

Food scientist Hang Xiao of the University of Massachusetts Amherst recently received a four-year, $491,220 grant to study the biochemical fate of nanoemulsion-based food delivery systems in the gastrointestinal (GI) tract, hoping to re-shape them and enhance the absorption of beneficial food components encapsulated in delivery systems.

20 Jan 2014

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

Otsuka Pharmaceutical Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted the submission of a marketing authorisation application (MAA) for the potential approval of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD).

27 Dec 2013

New antimicrobial coating prevents infections during cold winter months

With cold and flu season now in full swing, all-natural wellness provider Neutra Corp. (OTCBB: NTRR) is working quickly to deliver a revolutionary new antimicrobial coating that could soon prove to be the best defense against infections and viruses in the most notorious hotspot for the spread of these diseases: the classroom.

11 Dec 2013

Vestiage selects ROI Media for direct to consumer marketing campaign

Vestiage, Inc., a publicly traded healthy aging lifestyle company focused on science-based premium branded highly potent cosmeceuticals and nutraceuticals, announced today that it has engaged ROI Media to orchestrate its direct to consumer marketing campaign.

11 Dec 2013

Otsuka, Lundbeck to develop investigational vaccine candidate for Alzheimer's disease

H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that they will further expand their collaboration to include the development of Lu AF20513, an investigational vaccine candidate for Alzheimer's disease.

11 Dec 2013

Purlife inks deal with Canada-based auto warranty company

Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, is proud to announce that its partner, Purlife, has signed a deal with one of Canada's largest automotive warranty companies to make its revolutionary Drivepur Protection System available to a network of 1,200 car dealerships.

26 Nov 2013

Nutranomics joins Genesar Nutraceuticals to acquire worldwide licence for GenEpic

Nutranomics, Inc. is pleased to announce that the Company has completed a Licence Agreement with Genesar Nutraceuticals, LLC to acquire the worldwide exclusive marketing and distributing rights to GenEpic, a natural therapeutic treatment formula currently the subject of an IRB reviewed phase II human clinical study on prostate cancer treatment and recovery.

25 Nov 2013

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.

25 Nov 2013

S2O2 finalizes acquisition of Texas-based sanitation technology innovator

Neutra Corp., a growing provider of all-natural wellness solutions, announced today that its joint venture partner Surface to Air Solutions is finalizing the acquisition of a sanitation technology innovator dedicated to greatly reducing the risk of staph infection in sports.

12 Nov 2013

Locker rooms from local high school to NFL, concern about spread of deadly infections

In locker rooms from your local high school to the National Football League, concern about the spread of potentially deadly bacteria and infections are leading training staffs to take extreme measures to prevent outbreaks. Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, could be close to offering a solution to the problem.

7 Nov 2013

Natura Therapeutics’ natural dietary intervention improves older adults' cognitive functioning

A human clinical study of older adults has demonstrated that participants who took NutraStem Cardio-, a natural dietary supplement created by Natura Therapeutics, Inc., showed a significant increase in cognition when compared to age-matched individuals taking a placebo.

7 Nov 2013

Hemp shareholders set to receive additional stock in Bioadaptives

Hemp, Inc., shareholders are set to receive additional stock in BioAdaptives, Inc. Executives of Hemp, Inc. solidified the all-stock deal with BioAdaptives, Inc. by selling the assets of its subsidiary, BioSwan, Inc. on October 25, 2013.

31 Oct 2013

New all-natural technology can eliminate molds and pesticides in cannabis products

As medical marijuana states crack down on pesticides, molds and other adulterants in cannabis products, Neutra Corp. is helping to develop new technology to keep patients safe from potentially harmful contamination.

30 Oct 2013

Nutraceutical News and Research

Further Reading

Study identifies role of additive monosodium glutamate in obesity and liver disease

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Neutra to unveil new vapor pen at Cannabis Cup trade show

Neutra seeks new breakthroughs in greenhouse cultivation to develop and market around globe

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Omega Protein's fourth quarter 2013 revenues increase 4% to $66 million

Neutra acquires cutting-edge developer of smoke-free nutraceutical delivery systems

Scientist receives grant to study biochemical fate of nanoemulsion-based food delivery systems in GI tract

EMA accepts Otsuka's marketing authorisation application for tolvaptan for treatment of ADPKD

New antimicrobial coating prevents infections during cold winter months

Vestiage selects ROI Media for direct to consumer marketing campaign

Otsuka, Lundbeck to develop investigational vaccine candidate for Alzheimer's disease

Purlife inks deal with Canada-based auto warranty company

Nutranomics joins Genesar Nutraceuticals to acquire worldwide licence for GenEpic

CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis

S2O2 finalizes acquisition of Texas-based sanitation technology innovator

Locker rooms from local high school to NFL, concern about spread of deadly infections

Natura Therapeutics’ natural dietary intervention improves older adults' cognitive functioning

Hemp shareholders set to receive additional stock in Bioadaptives

New all-natural technology can eliminate molds and pesticides in cannabis products

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News